Apr. 30 - The Medical College of Wisconsin (MCW) has received a five-year, $1.75 million grant from the National Institutes of Health’s National Cancer Institute to study a new approach at limiting the spread of breast cancer.
Apr. 28 - Christopher Olsen, PhD, (Pharmacology & Toxicology) and Matthew Budde, PhD, (Neurosurgery) are co-investigators of a two-year, $420,000 grant from the National Institute on Drug Abuse to study the link between traumatic brain injury and substance abuse disorder. Waukesha Now
Apr. 16 - The Medical College of Wisconsin (MCW) has received a two-year, $420,000 grant from the National Institutes of Health’s National Institute on Drug Abuse to research the link between traumatic brain injury (TBI) and substance abuse disorder.
Feb. 3 - Donghai Xiong, PhD was lead author of a study published in the American Journal of Human Genetics that identified a gene associated with lung cancer.
Milwaukee Journal Sentinel, Fox 6 Now and Science Daily
Jan. 29 - Donghai Xiong, PhD, assistant professor of pharmacology and toxicology at MCW; and Ming You, MD, PhD, the Joseph F. Heil Jr. Professor of Oncogenesis and Director of the Cancer Center, have linked a gene associated with Parkinson’s Disease to familial lung cancer. Milwaukee Journal Sentinel
Dec. 8 - A Milwaukee Journal Sentinel article details research by John Baker, PhD on the long-term risks of heart disease faced by astronauts due to radiation exposure. Milwaukee Journal Sentinel
Dec. 8 - USA Today quotes Dr. Kiran Turaga regarding the treatment of a patient with a 19-pound abdominal tumor. Dr. Turaga reports that the patient had a rare form of Liposarcoma. USA Today and The Northwestern
Sept. 29 - The 20th annual Ridin’ to a Cure event was held in Oconomowoc on September 27. Fox 6 News covered the ride’s kickoff live. Carol Williams, PhD, professor of pharmacology and toxicology at MCW and a breast cancer researcher, is a regular participant in the ride. She was interviewed for the story. WITI TV
Sept. 25 - The Medical College of Wisconsin (MCW) will explore the feasibility of opening a school of pharmacy. A feasibility study will include several considerations related to an immersive three-year curricular model, class size, tuition, and a distributed model with possible campuses in Green Bay or Central Wisconsin.
Sept. 24 - Cecilia Hillard, PhD is co-primary investigator of a one-year, $50,000 grant from the Clinical and Translational Science Institute of Southeast Wisconsin to study the treatment of post-traumatic stress disorder. Wauwatosa Now
Sept. 17 - A collaborative team of researchers from Marquette University and the Medical College of Wisconsin has received a one-year, $50,000 grant from the Clinical and Translational Science Institute of Southeast Wisconsin to study treatment for post-traumatic stress disorder.
Sept. 02 - William B. Campbell, PhD has been named as MCW’s first Eminent Scholar. The Eminent Scholar program recognizes and rewards excellence in academic and scholarly achievement that ordinarily would be funded from an endowed chair. MCW names one Eminent Scholar every year, and the term is five years. Wauwatosa Now
Aug. 21 - William Campbell, PhD, Professor and Chair, Pharmacology & Toxicology, was awarded an Eminent Scholar designation at the July meeting of the Board of Trustees of the Medical College of Wisconsin.
June 30 - Cecilia Hillard, PhD is co-principal investigator of a $2.6 million NIH grant awarded to John Mantsch, PhD, of Marquette University. The joint MCW/Marquette study will investigate the effects of stress in drug addiction relapse. Milwaukee Journal Sentinel and GM Today
June 24 - Milwaukee was selected as the site for the 60th annual meeting of the International Society on Thrombosis and Haemostasis because of the quality of research work conducted by MCW and the BloodCenter of Wisconsin. Milwaukee Biz Times
June 24 - Researchers at MCW and Marquette University have earned a five-year grant to study addiction: cravings, relapse, and stress. Cecilia Hillard, PhD, professor of pharmacology and toxicology and director of the Neuroscience Research Center at MCW, is a co-PI on the grant. Milwaukee Journal Sentinel
June 18 - Qing-Song Liu, PhD received a five-year, $1.6 million grant from the National Institute on Drug Abuse to study the mechanisms by which phosphodiesterase (PDE) inhibitors reduce addictive behaviors. Wauwatosa Now
June 12 - The Medical College of Wisconsin has received a five-year, $1.6 million grant from the National Institutes of Health’s National Institute on Drug Abuse to study the mechanisms by which phosphodiesterase inhibitors reduce addictive behaviors.
Maureen MackDirector of External Communications(414) 955-4744 (Office)(414) 750-5266 (Cell)firstname.lastname@example.org
Richard N. KatschkeAssociate Vice President(414) email@example.com
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
Directions & Maps